Innate Pharma Stock (NASDAQ: IPHA) stock price, news, charts, stock research, profile.
You can purchase shares of Innate Pharma (NASDAQ:IPHA) through any online brokerage.
Other companies in Innate Pharma’s space includes: Outlook Therapeutics (NASDAQ:OTLK), Skye Bioscience (NASDAQ:SKYE), Galectin Therapeutics (NASDAQ:GALT), Adverum Biotechnologies (NASDAQ:ADVM) and Inovio Pharmaceuticals (NASDAQ:INO).
Innate Pharma has a consensus price target of $10.83.
The stock price for Innate Pharma (NASDAQ: IPHA) is $1.82 last updated October 24, 2024 at 7:24 PM EDT.
There are no upcoming dividends for Innate Pharma.
Innate Pharma’s H1 earnings are confirmed for Thursday, September 12, 2024.
There is no upcoming split for Innate Pharma.
Innate Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.